Our Offices

CSL Moves Up International Biotech Market Capitalisation Rankings Driven By R&D Investment

A report in the Australian Financial Review has highlighted the remarkable performance of CSL over recent years, largely due to the company’s investment in R&D Activity. The report has highlighted: CSL’s share price has increased more than 50% during 2019, […]

Fintech Australia Uses Fintech And Regtech Senate Inquiry To Highlight Importance Of The R&D Tax Incentive

In December 2019, Fintech Australia released its response to the Financial Technology and Regulatory Technology Senate inquiry.  Their committee voiced concerns regarding the Government’s plan to cut $1.35B from the R&D Tax Incentive and stated that the current definition of […]